Your session is about to expire
← Back to Search
TCA for Actinic Cheilitis
Study Summary
This trial compared the efficacy of TCA versus Placebo in the treatment of actinic cheilitis.
- Actinic Cheilitis
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the capacity for this clinical experiment?
"Affirmative. Clinicaltrials.gov has recorded that this clinical trial, which was initially posted on March 10th 2021, is currently recruiting participants. Altogether 50 people are required for the study at only one location."
Is there still room for participants in this experiment?
"Evidenced by information hosted on clinicaltrials.gov, this clinical investigation is currently enrolling participants and has been active since March 10th 2021. The details of the trial have been amended as recently as August 12th 2021."
Has the Food and Drug Administration given its stamp of approval for tricyclic antidepressants?
"Per our assessment, TCA has been granted a safety rating of 3 due to its success in Phase 4 trials and subsequent approval."
Share this study with friends
Copy Link
Messenger